Samsung Electronics has received approval from the US Food and Drug Administration (FDA) for the irregular heart rhythm notification (IHRN) feature included in the Samsung Health Monitor app.
The IHRN feature along with the app’s current on-demand Electrocardiogram (ECG) function monitors heart rhythms indicative of atrial fibrillation (AFib) right from the Samsung Galaxy Watch tied around an individual’s wrist.
This notification feature will be available as part of the forthcoming One UI 5 Watch, coming first to the upcoming Galaxy Watch devices later in 2023 and then expanding to earlier versions of the watch later.
